drugset / Trial / NCT00997672

Lithium in Multiple System Atrophy

NCT00997672

Phase 2 Terminated 10 enrolled Federico II University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine safety and tolerability of the treatment with lithium in Multiple System Atrophy. Moreover, clinical symptoms, neuronal loss, quality of life and depressive symptoms, will be considered to further investigate the effect of lithium therapy.

Timeline

Start
2009-10
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Carbonate Unknown 150 mg
Subject Lithium Carbonate Unknown 300 mg